DE3361138D1 - Ozone inactivated organisms as vaccines - Google Patents

Ozone inactivated organisms as vaccines

Info

Publication number
DE3361138D1
DE3361138D1 DE8383300483T DE3361138T DE3361138D1 DE 3361138 D1 DE3361138 D1 DE 3361138D1 DE 8383300483 T DE8383300483 T DE 8383300483T DE 3361138 T DE3361138 T DE 3361138T DE 3361138 D1 DE3361138 D1 DE 3361138D1
Authority
DE
Germany
Prior art keywords
vaccines
ozone
inactivated
inactivated organisms
microorganism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383300483T
Other languages
English (en)
Inventor
Yuan Chung Zee
David Cecil Bolton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Application granted granted Critical
Publication of DE3361138D1 publication Critical patent/DE3361138D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16163—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8383300483T 1982-02-09 1983-01-31 Ozone inactivated organisms as vaccines Expired DE3361138D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34856982A 1982-02-09 1982-02-09

Publications (1)

Publication Number Publication Date
DE3361138D1 true DE3361138D1 (en) 1985-12-12

Family

ID=23368584

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383300483T Expired DE3361138D1 (en) 1982-02-09 1983-01-31 Ozone inactivated organisms as vaccines

Country Status (10)

Country Link
EP (1) EP0086071B1 (de)
JP (1) JPS58201721A (de)
AT (1) ATE16348T1 (de)
AU (1) AU558008B2 (de)
CA (1) CA1212320A (de)
DE (1) DE3361138D1 (de)
DK (1) DK52783A (de)
IL (1) IL67818A (de)
NZ (1) NZ203094A (de)
ZA (1) ZA83640B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3345864A1 (de) * 1983-12-19 1985-06-27 Egbert Frh. von 8000 München Malsen-Ponickau Impfstoff und verfahren zu seiner herstellung
US4632980A (en) * 1985-04-03 1986-12-30 Immunologics Ozone decontamination of blood and blood products
DE3679298D1 (de) * 1985-12-20 1991-06-20 Du Pont Herstellung von tabletten aus mikrobiologischen substanzen.
FR2603805A1 (fr) * 1986-09-16 1988-03-18 Transfusion Sanguine Assoc Rgl Procede d'inactivation par ozonolyse de micro-organismes contaminants presents dans des materiaux biologiques essentiellement proteiques, les produits obtenus et leurs applications biologiques et analytiques
GB0603749D0 (en) * 2006-02-24 2006-04-05 Moving Sun Ltd Immune system stimulant and process of manufacturing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE471250A (de) *
CH173194A (de) * 1933-05-27 1934-11-15 Veterinaria A G Zuerich Verfahren zur Herstellung eines Impfstoffes zur aktiven Immunisierung von Menschen oder Tieren gegen anaerobe Krankheitskeime.
CH200180A (de) * 1936-03-26 1938-09-30 Frei Walter Dr Prof Verfahren zur Herstellung von Vaccinen.
GB1230414A (de) * 1968-07-09 1971-05-05

Also Published As

Publication number Publication date
IL67818A (en) 1987-03-31
AU1081283A (en) 1983-08-18
ZA83640B (en) 1984-03-28
EP0086071A1 (de) 1983-08-17
CA1212320A (en) 1986-10-07
AU558008B2 (en) 1987-01-15
NZ203094A (en) 1986-04-11
IL67818A0 (en) 1983-06-15
EP0086071B1 (de) 1985-11-06
ATE16348T1 (de) 1985-11-15
DK52783D0 (da) 1983-02-08
DK52783A (da) 1983-08-10
JPS58201721A (ja) 1983-11-24

Similar Documents

Publication Publication Date Title
ZA938203B (en) Urease-based vaccine against helicobacter infection
AU6750181A (en) Vaccinal complex containing a specific antigen and vaccine containing it
CA2134835A1 (en) Live in ovo vaccine
ES2092306T3 (es) Adyuvante para vacunas.
EP0145783A4 (de) Impfstoff gegen hundecoronavirus.
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
CH614718A5 (en) Process for the preparation of glucosamine derivatives
AU2152988A (en) Intranasal vaccination of horses with inactivated microorganisms or antigenic material
ES8802209A1 (es) Procedimiento de acondicionar preparados de vacunas inyectables a animales.
ES2244617T3 (es) Vacunas a base de salmonelas en las cuales los genes ssa han sido inactivados.
GR3022755T3 (en) Chicken anaemia agent vaccine
DE3361138D1 (en) Ozone inactivated organisms as vaccines
GB8910570D0 (en) Acellular vaccine
EP0256792A3 (en) Vaccines for fowl colibacillosis
EP0636030A4 (de) Impfstoff gegen das bacterientoxoid aus -i (pasteurellia haemolytica).
JPS5781417A (en) Human immunity effect imparting vaccine against escherichia coli infectious desease
RU93005000A (ru) Композиция вакцин, способ ее получения, способ исключения иммунной реакции
IL106903A0 (en) Bacterial vaccines using vaccine strains of pathogenic bacterial

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee